Revolution Medicines (RVMD) Leases (2020 - 2025)
Historic Leases for Revolution Medicines (RVMD) over the last 6 years, with Q3 2025 value amounting to $134.4 million.
- Revolution Medicines' Leases rose 8086.31% to $134.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.4 million, marking a year-over-year increase of 8086.31%. This contributed to the annual value of $117.5 million for FY2024, which is 5234.68% up from last year.
- Revolution Medicines' Leases amounted to $134.4 million in Q3 2025, which was up 8086.31% from $114.0 million recorded in Q2 2025.
- Over the past 5 years, Revolution Medicines' Leases peaked at $134.4 million during Q3 2025, and registered a low of $25.0 million during Q1 2023.
- Moreover, its 5-year median value for Leases was $58.6 million (2022), whereas its average is $67.4 million.
- Its Leases has fluctuated over the past 5 years, first soared by 21524.56% in 2021, then plummeted by 5731.6% in 2023.
- Revolution Medicines' Leases (Quarter) stood at $59.7 million in 2021, then fell by 7.73% to $55.1 million in 2022, then skyrocketed by 40.07% to $77.1 million in 2023, then surged by 52.35% to $117.5 million in 2024, then rose by 14.39% to $134.4 million in 2025.
- Its Leases stands at $134.4 million for Q3 2025, versus $114.0 million for Q2 2025 and $115.8 million for Q1 2025.